• Knowledge Hubs
    • Conference Coverage
      • Roundtables
        • The Uromigos
          • Uromigos Live 2024
            • AUC3
              • Calendar
                Main Logo
                focus
                Key Biomarker Analysis Highlights Effectiveness of Pembrolizumab, Axitinib in Advanced Renal Cell Carcinoma
                Brandon TwyfordAdvanced Renal Cell Carcinoma | June 10, 2024
                The KEYNOTE-426 study explored pembrolizumab and axitinib vs sunitinib in advanced RCC using genetic biomarkers.
                Read More

              • 630 Madison Ave.

                Manalapan, NJ 07726

                • About

                About Us

                Contributors and Partners

                Editorial Policy

                Advertising

                Connect

                eNewsletters

                Calendar

                Contact Us

                Contribute

                Our Network

                MashupMD

                Cancer Nursing Today

                Urban Health Today

                Blood Cancers Today

                DocWire News

                Formedics logo© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

                Terms of Use | Privacy Policy |